Mast cell activation may contribute to adverse health transitions in COVID-19 patients with frailty
A prominent aspect of the post-coronavirus disease-2019 (post-COVID-19) era is long-COVID. Therefore, precise patient classification and exploration of the corresponding factors affecting long-COVID are crucial for tailored treatment strategies. Frailty is a common age-related clinical syndrome char...
Saved in:
| Main Authors: | Xiangqi Li, Chaobao Zhang, Zhijun Bao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2023-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2023.2251589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mast cell activation syndrome: The overdiagnosis problems
by: N. V. Mikryukova, et al.
Published: (2025-06-01) -
Mast cells in lung of rat
by: I. Ivanova
Published: (2017-09-01) -
On the Role of Mast Cells and Their Proteases in the Severe COVID-19
by: A. V. Budnevsky, et al.
Published: (2024-06-01) -
Bone marrow mast cells and mast cell tryptase in plasma cell disorders
by: Raveena Yadav, et al.
Published: (2025-03-01) -
Interrelation of mast cells with spermatogenesis in norm and in case of damage
by: Yu. S. Khramtsova, et al.
Published: (2019-05-01)